Ghana

Reimbursed Care Access

Ghana regulates psychedelic and psychotropic substances under the Narcotics Drugs (Control, Enforcement and Sanctions) Law, 1990 (PNDCL 236) and through the Narcotics Control Commission; classical psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, 2C‑X, ibogaine, ayahuasca constituents) are treated as controlled/illegal outside of tightly controlled contexts, while ketamine is available and routinely used as an anaesthetic within hospitals. There is no public record of registration or routine clinical/insured use of newer regulated psychedelic medicines (e.g., esketamine/Spravato) in Ghana at national level; access to psychedelic compounds for psychiatry would be limited to hospital anaesthetic use (ketamine), approved clinical research, or exceptional authorised importation under licence. [https://ghanalegal.com/laws_subdomain/acts/id/538/narcotic-drugs-control_-enforcement-and-sanctions-law/|PNDCL 236] [https://www.mint.gov.gh/agencies/narcotic-control-board/|Narcotics Control Commission (Ghana)]